Stock Taper 
LIMN
$4.23
▼ DOWN 3.86% (-0.17)
KEY STATISTICS
Market Cap$5.68 M
52w High$154.50
52w Low$4.23
Dividend Yield—
Frequency—
P/E-23.50
Volume38.00K
Shares Out.1.34M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Chris Kim
COMPENSATION 2026
Salary$183,333
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$0
Total$183,333
ABOUT
SECTOR
Healthcare
WENT PUBLIC
May 1, 2025
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
1
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2026-08-21 | Reverse | 1:50 |
PRICE
$4.23 ▼ DOWN 3.86% (−$0.17)About Liminatus Pharma, Inc. Class A Common Stock
https://liminatuspharma.com ↗Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
INDUSTRY
Biotechnology
A PRODUCT LIMINATUS PHARMA, INC. CLASS A COMMON STOCK IS KNOWN FOR
GCC Vaccine
A cancer vaccine candidate currently in Phase II clinical trials. It is designed to stimulate an immune response against various cancers that express Guanylyl Cyclase C, such as colorectal, pancreatic, gastric, and esophageal cancers.
ETFS HOLDING THIS STOCK
ETFS HOLDING
1
LISTED HERE
1
RANKED BY POSITION SIZE
RATINGS SNAPSHOT
Overall rating: D+
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score1
INSIDER TRADES
★
10 PERCENT OWNER
Valetudo Therapeutics LLC
Purchase · 3.4M shares
2026-07-02
★
10 PERCENT OWNER
Valetudo Therapeutics LLC
Sale · 4.4M shares
2026-06-24
★
10 PERCENT OWNER
Ewon Comfortech Co., Ltd.
— · —
2026-06-24
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 SABS | $3.79 | COMPARE |
 ATHE | $4.51 | COMPARE |
 DYAI | $0.61 | COMPARE |
 EVAX | $3.01 | COMPARE |
 JSPR | $0.70 | COMPARE |
 BTAI | $0.18 | COMPARE |